Alterations in respiratory behavior, brain neurochemistry and receptor density induced by pharmacologic suppression of sleep in the neonatal period

Citation
Aj. Thomas et al., Alterations in respiratory behavior, brain neurochemistry and receptor density induced by pharmacologic suppression of sleep in the neonatal period, DEV BRAIN R, 120(2), 2000, pp. 181-189
Citations number
41
Categorie Soggetti
Neurosciences & Behavoir
Journal title
DEVELOPMENTAL BRAIN RESEARCH
ISSN journal
01653806 → ACNP
Volume
120
Issue
2
Year of publication
2000
Pages
181 - 189
Database
ISI
SICI code
0165-3806(20000414)120:2<181:AIRBBN>2.0.ZU;2-1
Abstract
The present study examined if drug suppression of active sleep (AS) in the neonate affected the development and expression of respiratory behavior. Se condly, we assessed brain neurochemistry acid receptor density in specific supra-medullary brain regions to identify coincident biochemical alteration s. Sprague-Dawley newborn rat pups were randomized and divided among six ra t mothers (n = 10/mother/group), each mother housed separately. Two untreat ed control (UC) groups received either no interventions or were fed milk ve hicle twice daily and were handled similarly to the drug intervention anima ls. Pharmacological disruption of sleep was achieved by administration (2 g roups of each) of either clonidine (CLO) 100 mu m/kg, or scopolamine (SCO) 800 mu m/kg, given orally twice daily for the first 7 days of life. On post natal (P) days P10 and P19 of life, pups were assessed for metabolism, minu te ventilation (V-E), tidal volume (V-t) and frequency (f). On P21 (14 days after the end of drug exposure), pups from each condition were sacrificed and punch biopsies of the frontal cortex, hypothalamus, and hippocampus wer e examined for hydroxytryptophan (5-HT), and norepinepherine (NE) by HPLC. An equal number of pups were sacrificed and brains examined for muscarinic acetylcholine (mAch), alpha(2)-adrenergic and I-1-imidazoline receptor dens ity. Results: Both CLO and SCO exposed animals had a lower V-t and respirat ory quotient than UC animals (p < 0.01). CLO animals exhibited a higher f ( p < 0.01) and both CLO and SCO exhibited a lower V-t (p < 0.05) than the UC groups; V-E was reduced in the SCO groups, compared with CLO and UC groups (p < 0.01). Pattern of breathing in response to brief hypoxia exposure was altered for CLO and SCO, The normal decline in V-E during sleep was not ob served in CLO rats. Both drug exposures resulted in a comparable reduction in hypothalamic NE and 5-HT levels (p < 0.05), while in the frontal cortex, and the hippocampus variable changes in NE and 5-HT, occurred. In CLO and SCO rats mAch receptors were increased in cortex, and reduced in hypothalam us; I-1-imidazoline receptors were increased in hypothalamus and decreased in hippocampus (p < 0.05 for each). in contrast, alpha(2)-adrenergic recept ors were increased in cortex for both CLO and SCO, decreased in hypothalamu s for CLO, and decreased in hippocampus for SCO (p < 0.05 for each). Conclu sions: these data show that drug-induced neonatal sleep suppression will al ter ventilatory pattern, metabolism, and site-specific concentrations of ad renergic neurotransmitters and in receptor density, perhaps as a result of suppression of neonatal AS. (C) 2000 Elsevier Science B.V. All rights reser ved.